Financial News
Ascendis Pharma ADR (NQ: ASND )
139.68
+0.29
(+0.21%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Ascendis Pharma ADR
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Recap: Ascendis Pharma Q3 Earnings
November 07, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Preview: Ascendis Pharma's Earnings
November 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Ascendis Pharma
October 09, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/28/bmrn.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Ascendis Pharma
September 07, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
September 05, 2023
From Royalty Pharma plc
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
Earnings Preview For Ascendis Pharma
September 04, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Analyst Expectations for Ascendis Pharma's Future
July 24, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Where Ascendis Pharma Stands With Analysts
June 20, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
The Latest Analyst Ratings for Ascendis Pharma
June 01, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/01/asnd.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://g.foolcdn.com/editorial/images/730370/medstocks.jpg)
![](https://g.foolcdn.com/editorial/images/727392/fda-blocks-in-hand.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
![](https://cdn.benzinga.com/files/images/story/2023/05/01/image24.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/20/wall_street_shutter3.jpg?width=1200&height=800&fit=crop)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/options_image_675.jpeg?width=1200&height=800&fit=crop)
10 Health Care Stocks With Whale Alerts In Today's Session
April 12, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230407005152/en/538768/22/BES_Mark.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://mms.businesswire.com/media/20230404006094/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.